BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16445420)

  • 1. Cutaneous leishmaniasis: three children with Leishmania major successfully treated with itraconazole.
    White JM; Salisbury JR; Jones J; Higgins EM; Vega-Lopez F
    Pediatr Dermatol; 2006; 23(1):78-80. PubMed ID: 16445420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral fluconazole treatment for extensive cutaneous leishmaniasis in an 11-year-old child.
    Toubiana J; Armengaud JB; Dupouy Camet J; Gendrel D
    Pediatr Infect Dis J; 2006 Nov; 25(11):1083-4. PubMed ID: 17072139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous leishmaniasis: successful treatment with itraconazole.
    Consigli J; Danielo C; Gallerano V; Papa M; Guidi A
    Int J Dermatol; 2006 Jan; 45(1):46-9. PubMed ID: 16426375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M; Anwar AE
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.
    Alrajhi AA; Ibrahim EA; De Vol EB; Khairat M; Faris RM; Maguire JH
    N Engl J Med; 2002 Mar; 346(12):891-5. PubMed ID: 11907288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study.
    Momeni AZ; Jalayer T; Emamjomeh M; Bashardost N; Ghassemi RL; Meghdadi M; Javadi A; Aminjavaheri M
    Arch Dermatol; 1996 Jul; 132(7):784-6. PubMed ID: 8678570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous sporotrichoid leishmaniasis resistant to pentavalent antimonial therapy: complete resolution with itraconazole.
    Cozzani E; Satta R; Fausti V; Cottoni F; Parodi A
    Clin Exp Dermatol; 2011 Jan; 36(1):49-51. PubMed ID: 20545956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis.
    Nassiri-Kashani M; Firooz A; Khamesipour A; Mojtahed F; Nilforoushzadeh M; Hejazi H; Bouzari N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):80-3. PubMed ID: 15649196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of itraconazole and terbinafine on Leishmania major lesions in BALB/c mice.
    Zakai HA; Zimmo SK
    Ann Trop Med Parasitol; 2000 Dec; 94(8):787-91. PubMed ID: 11214097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole in the treatment of cutaneous leishmaniasis.
    Firooz A; Khatami A; Dowlati Y
    Int J Dermatol; 2006 Dec; 45(12):1446-7. PubMed ID: 17184256
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous leishmaniasis in Nepal: Leishmania major as a cause.
    Kumar R; Ansari NA; Avninder S; Ramesh V; Salotra P
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):202-3. PubMed ID: 18177679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Pediatric case of lupoid leishmaniasis diagnosed by PCR].
    Paradisi M; Grosso MG; Angelo C; Gradoni L; Ludovisi A; N'Doni F; Puddu P
    Minerva Pediatr; 2001 Feb; 53(1):33-7. PubMed ID: 11419394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous leishmaniasis due to Leishmania major involving the bone marrow in an AIDS patient in Burkina Faso].
    Barro-Traoré F; Preney L; Traoré A; Darie H; Tapsoba P; Bassolé A; Sawadogo S; Niamba P; Grosshans E; Geniaux M
    Ann Dermatol Venereol; 2008 May; 135(5):380-3. PubMed ID: 18457724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous leishmaniasis in a child treated with oral fluconazole.
    Sklavos AV; Walls T; Webber MT; Watson AB
    Australas J Dermatol; 2010 Aug; 51(3):195-7. PubMed ID: 20695859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment.
    Marovich MA; Lira R; Shepard M; Fuchs GH; Kruetzer R; Nutman TB; Neva FA
    Clin Infect Dis; 2001 Oct; 33(7):1076-9. PubMed ID: 11528583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous leishmaniasis treated with itraconazole.
    Baroni A; Aiello FS; Vozza A; Vozza G; Faccenda F; Brasiello M; Ruocco E
    Dermatol Ther; 2009 Nov; 22 Suppl 1():S27-9. PubMed ID: 19891689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old world cutaneous leishmaniasis infection in children: a case series.
    Jones J; Bowling J; Watson J; Vega-Lopez F; White J; Higgins E
    Arch Dis Child; 2005 May; 90(5):530-1. PubMed ID: 15851441
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of itraconazole for sporotrichosis in Japan: study of three cases and literature comparison of therapeutic effects before and after release on the market.
    Kikuchi I; Morimoto K; Kawana S; Tanuma H
    Eur J Dermatol; 2006; 16(1):42-7. PubMed ID: 16436341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.